Research Associate - ADAPT Trial and Patient Engagement Lead

Salary on appointment will be £31,236 per annum (pro rata), with an annual increment up to £37,694 per annum (pro rata)

An exciting opportunity has arisen for a Research Associate join the Norwich Medical School to conduct studies on interventions to help people with rheumatological diseases adapt to living with their disease(s).
 
As a Research Associate you will contribute to the research programme, analyse and interpret data, write up results and present information on research progress and outcomes.

You will have a graduate level qualification, equivalent qualification or experience and be able to work in a proactive and results driven manner in a high paced environment. You will also have strong interpersonal and communication skills, the ability to analyse and interpret data and work effectively as part of a team. Advanced skills directly relating to this research area and previous research experience would be advantageous.  
 
This part-time (0.2 FTE) post is available for 1 day a week (flexibly around your availability) for a fixed term period of 14 months.

Details of preferred hours should be stated in the personal statement and will be discussed further at interview.

We value diversity and are committed to creating an inclusive culture where everyone can thrive. We particularly welcome applicants with the protected characteristic of a disability, especially those with lived experience of autoimmune rheumatic disease for this post, as such insight and understanding are highly relevant to the work within the Long-Term Conditions Research Group. Appointment will be made on merit and all applicants will be scored against the same criteria. 

Further information on our great benefits package, including 44 days annual leave inclusive of Bank Holidays and additional University Customary days (pro rata for part-time), can be found on our benefits page.

Closing date: 17 November 2025

The University holds an Athena Swan Silver Institutional Award in recognition of our advancement towards gender equality.

Advert information